Boston Chief Medical Officer Summit Announces Keynotes

Share Article

The CMO Summit Confirms Keynotes from The New England Journal of Medicine, Alnylam Pharmaceuticals, Scripps Translational Science Institute, Tufts CSDD and the Cystic Fibrosis Foundation

Chief Medical Officer Summit Logo

The Conference Forum is delighted to announce its keynote speakers for the 4th Annual Chief Medical Officer Summit to be held on May 11-12, 2016 at the Colonnade Hotel in Boston.

Program keynotes include Jeff Drazen, MD, The New England Journal of Medicine, Akshay Vaishnaw, MD, PhD, Alnylam Pharmaceuticals, Don Jones, Scripps Translational Science Institute, Ken Getz, MBA, Tufts CSDD and Robert J Beall, PhD, The Cystic Fibrosis Foundation.

Morning day one keynote address starts with Dr Bob Beall of the Cystic Fibrosis Foundation on Profound Industry Impact: Leadership Talk on Expediting Drug Development & Commercialization for the Benefit of the Patients. Dr Beall pioneered the Foundation’s successful venture philanthropy model, which has been a game changer in CF research and drug development. In this session Dr Beall discusses the collaboration between the Cystic Fibrosis Foundation and Vertex, which produced a successful drug approval and drove a $3.3 billion deal.

Next, Dr Akshay Vaishnaw will address Challenges and Opportunities in Pursuing a New Therapeutic Modality from its Inception. As the CMO at the leading RNAi therapeutics company Dr Vaishnaw is perfectly positioned to offer valuable insights into what to expect from undertaking a new therapeutic modality.

Following Dr Vaishnaw, Dr Jeff Drazen, the New England Journal of Medicine uses tuberculosis as the example of improving evidence-based understanding and shares his point of view on academic-industry relationships in his keynote address “The Play of Chance: The Rise of Evidence.”

During the afternoon, Donald Jones, Scripps Translational Science Institute will present the technology keynote on Digital solutions Impacting the Economic Efficacy of Clinical Trials. In this session internationally recognized digital health expert, Donald Jones, will share his insights on the digital clinical trial landscape and the urgent need to pair digitization with drug products for patients.

On day two of the conference, Ken Getz, Tufts CSDD will present his annual keynote address on Isolating Operating Barriers to Achieving Capital and Asset Efficient Drug Development.

About the Chief Medical Officer Summit:

The summit is dedicated to accomplishing two goals.

  • To bring together CMO and R&D leadership from emerging biotechs to address the unique challenges associated with directing and managing all R&D functions with limited resources, while raising capital and strategizing for appropriate exits.
  • To create a network of CMOs and R&D Leadership from small to mid-size life science companies to share ideas, solutions and support.

About the Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. Its mission is to create the best content and networking for life science executives to help move therapeutics to patients faster.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jessica Rothenberg
Follow us on
Visit website